Recent studies have indicated that type I and type II interferon preparations have a time-and dosage-dependent immunoregulatory effect. Incubation of murine spleen cell cultures with interferon 24 h before or simultaneously with sensitization of the cultures to sheep erythrocytes (SRBC) resulted in the marked inhibition of the anti-SRBC plaque-forming cell (PFC) response (9, 12) . Addition of interferon to the cultures after sensitization with SRBC enhanced the anti-SRBC PFC response (6, 13) . In vivo administration of high dosages of interferon had an immunosuppressive effect, whereas lower amounts had an immunoenhancing effect (13) .
One class of type I interferon inducers is characterized by high molecular weight, high density of anionic groups, and limited degradability by mammalian cells (11) . Certain compounds of this class of inducers, such as dextran sulfate and pyran copolymer, also have immunomodulatory effects (2, 5) . The sulfated polygalactan, carrageenan, exhibits the molecular characteristics described above and also has been shown to have both immunosuppressive (1) and immunoenhancing (E. V. Turner and R. D. Higginbotham, submitted for publication) effects on the antibody response to SRBC. In view of these similarities of carrageenan to other interferon inducers, the ability of carrageenan to induce interferon was deemed worthy of study.
All mice used in this study were 6-to 8-weekold Swiss-Webster females, and were obtained from Laboratory Supply Co., Inc., Indianapolis, Ind. Lambda and kappa carrageenan, gifts of Marine Colloids, Springfield, N.J., were suspended in saline. Appropriate dosages were injected intravenously (i.v.) and mice were exsanguinated at various time intervals as described below. Sera were assayed for antiviral activity. Control type I interferon was produced in L-929 cells by use of the Herts strain of Newcastle disease virus as previously described (8) . Culture supernatant fluids were harvested, and residual inducing virus was inactivated by exposure to pH 2 at 4VC for 5 days. The antiviral activity of the preparations was determined by means of a plaque reduction assay on mouse L-929 cells using the Indiana strain of bovine vesicular stomatitis virus as the challenge virus (3). The interferon titer corresponded to the reciprocal of the highest dilution of test sample that reduced plaques by 50%. In this assay, one interferon unit is equivalent to 0.88 National Institutes of Health no. G-002-904-551 reference unit.
The antiviral activity induced by carrageenan was characterized as interferon by the following procedures. The heat sensitivity of the activity in the preparations was determined by heating at 560C in a water bath for 1 h and then assaying for residual activity. Sensitivity to pH 2 was determined for these preparations by adjusting to pH 2 with 1 N HCl, incubating for 1 h, neutralizing with 1 N NaOH, and then assaying for residual activity. The preparations were exposed to 1 mg of trypsin per ml for 1 (14) , to determine the dosage for optimum production of antiviral activity. (Table 3) . Several polyanions such as dextran sulfate and pyran copolymer have been shown to be inducers of interferon (4), a property shared by lambda fraction of carrageenan as shown in the present study. The antiviral activity measurable after lambda carrageenan administration appears to be due to the induction of interferon, since the activity was sensitive to digestion by trypsin and was not expressed in the presence of actinomycin D (10) . This activity appears to be type I interferon due to its pH 2 stability and 560C lability (15).
Other work has shown that "Ebimar" (Evans Medical Ltd., Liverpool, England), a degraded preparation of seaplant polysaccharide that con- (4) . In the present study, lambda carrageenan but not kappa carrageenan induced interferon. Therefore, lambda carrageenan may be partly responsible for the interferon induction reported for Ebimar. Polyanionic agents such as pyran copolymer and dextran sulfate have also been shown to have immunomodulating effects. The lambda fraction of carrageenan has been similarly shown to influence immune responses in that administration of lambda carrageenan before antigenic stimulation with SRBC caused suppression of the immune response (1) whereas administration of this fraction at the time of antigenic stimulation resulted in an enhanced antibody response (Turner and Higginbotham, submitted for publication). These immunomodulatory effects are similar to those observed with interferon (6, 9, 12, 13) . The kappa fraction of carrageenan, which differs primarily from the lambda fraction by having a lesser degree of sulfation per molecule (7), has not been shown to have either immunosuppressive effects (1) or immunoenhancing effects (unpublished observations) on the antibody response to SRBC. The present study has shown that kappa carrageenan does not readily induce interferon. Therefore, the interferon induced by lambda carrageenan may contribute to the biological effects of this polyanion on immune responses.
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